Sheaf - I only got onto NRT in April so my knowledge before that is limited. My guess might be that they didn't raise enough capital last year to get enough funds to proceed to clinical studies and/or that the SBP technology may have been the first priority. Just a guess and if we end up getting into clinic early next year then 6-8 months late is not too much of a delay given all the boxes that have to be ticked along the way.
NRT Price at posting:
17.5¢ Sentiment: Buy Disclosure: Held